Abstract
Cancer is characterized as a serious public health problem. Particularly, bladder cancer has a high cost to health system, especially because the necessity of routine clinical monitoring (urine cytology and cystoscopy) and its high recurrence rate. Due to the complexity of biological systems, little is known about the molecular mechanisms responsible for urothelial carcinomas. Literature …